XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 327,974 $ 313,685
Marketable securities 151,466 151,687
Restricted cash, current 100 0
Accounts receivable, net 82,857 104,530
Prepaid expenses and other current assets 18,364 14,878
Deferred contract costs, current 40,953 30,234
Total current assets 621,714 615,014
Property and equipment, net 4,984 7,012
Capitalized software, net 30,924 27,412
Operating lease right-of-use assets 7,164 11,377
Restricted cash, non-current 3,429 3,629
Deferred contract costs, non-current 35,415 35,411
Strategic investments 10,311 12,104
Intangible assets, net 6,177 9,331
Goodwill 12,646 12,646
Other assets 3,730 3,632
Total assets 736,494 737,568
Current liabilities:    
Accounts payable 5,663 14,529
Accrued expenses and other current liabilities 31,040 31,247
Content costs payable 37,816 37,310
Accrued compensation and benefits 25,313 22,882
Operating lease liabilities, current 6,974 7,002
Deferred revenue, current 279,646 273,937
Total current liabilities 386,452 386,907
Operating lease liabilities, non-current 1,657 6,545
Deferred revenue, non-current 2,520 4,342
Other liabilities, non-current 26 464
Total liabilities 390,655 398,258
Note 8 – Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.00001 par value - 50,000,000 shares authorized; zero shares issued and outstanding as of September 30, 2023, and December 31, 2022. 0 0
Common stock, $0.00001 par value - 950,000,000 shares authorized; 152,661,464 and 145,013,786 shares issued and outstanding as of September 30, 2023, and December 31, 2022, respectively. 2 1
Additional paid-in capital 1,045,349 951,946
Accumulated other comprehensive loss (62) (233)
Accumulated deficit (699,450) (612,404)
Total stockholders’ equity 345,839 339,310
Total liabilities and stockholders' equity $ 736,494 $ 737,568